Cargando…
LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type
Stimulation testing is used to diagnose adrenal insufficiency. The low dose stimulation test uses Cosyntropin 1 mcg to measure cortisol when pituitary disease is suspected. Protocols call for cortisol levels at baseline, 30, and 60 minutes post-administration. A passing peak cortisol threshold of 18...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625680/ http://dx.doi.org/10.1210/jendso/bvac150.1230 |
_version_ | 1784822560554221568 |
---|---|
author | Lutz, Natalie Linn Larson Barger, Katie Newbern, Dorothee Oatman, Oliver Wilson, Rochelle Shaibi, Gabriel Q Beauregard, Susan Velasquez, Amy Kapadia, Chirag R |
author_facet | Lutz, Natalie Linn Larson Barger, Katie Newbern, Dorothee Oatman, Oliver Wilson, Rochelle Shaibi, Gabriel Q Beauregard, Susan Velasquez, Amy Kapadia, Chirag R |
author_sort | Lutz, Natalie Linn Larson |
collection | PubMed |
description | Stimulation testing is used to diagnose adrenal insufficiency. The low dose stimulation test uses Cosyntropin 1 mcg to measure cortisol when pituitary disease is suspected. Protocols call for cortisol levels at baseline, 30, and 60 minutes post-administration. A passing peak cortisol threshold of 18 mcg/dl is often used. In 2019, most cortisol assays in our area shifted to more sensitive methods; these are reported to require a lower pass threshold of 12 -14 mcg/dl. We did a retrospective review on 186 consecutive patients in whom newer assays were used, to describe pass/fail rates by timepoint/threshold. Using newer assays, and cortisol cut-off of 14 mcg/dl, a significantly higher percentage pass than if one used newer assays with the older cut-off of 18 mcg/dl (84.9% vs 72%.). When a cut-off of 14 is used, a 60 min assay adds little (pass rate including only 0 and 30 min values =83.3%; pass rate if include 0, 30, and 60 min values = 84.9%). We suggest that with newer assays, interpreting with a 14 mcg/dl cut-off shows higher pass rate than with 18 mcg/dl cut-off. We also suggest that when using newer assays and cut-off of 14 mcg/dl, 60 min assays add little. Presentation: No date and time listed |
format | Online Article Text |
id | pubmed-9625680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96256802022-11-14 LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type Lutz, Natalie Linn Larson Barger, Katie Newbern, Dorothee Oatman, Oliver Wilson, Rochelle Shaibi, Gabriel Q Beauregard, Susan Velasquez, Amy Kapadia, Chirag R J Endocr Soc Pediatric Endocrinology Stimulation testing is used to diagnose adrenal insufficiency. The low dose stimulation test uses Cosyntropin 1 mcg to measure cortisol when pituitary disease is suspected. Protocols call for cortisol levels at baseline, 30, and 60 minutes post-administration. A passing peak cortisol threshold of 18 mcg/dl is often used. In 2019, most cortisol assays in our area shifted to more sensitive methods; these are reported to require a lower pass threshold of 12 -14 mcg/dl. We did a retrospective review on 186 consecutive patients in whom newer assays were used, to describe pass/fail rates by timepoint/threshold. Using newer assays, and cortisol cut-off of 14 mcg/dl, a significantly higher percentage pass than if one used newer assays with the older cut-off of 18 mcg/dl (84.9% vs 72%.). When a cut-off of 14 is used, a 60 min assay adds little (pass rate including only 0 and 30 min values =83.3%; pass rate if include 0, 30, and 60 min values = 84.9%). We suggest that with newer assays, interpreting with a 14 mcg/dl cut-off shows higher pass rate than with 18 mcg/dl cut-off. We also suggest that when using newer assays and cut-off of 14 mcg/dl, 60 min assays add little. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9625680/ http://dx.doi.org/10.1210/jendso/bvac150.1230 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Pediatric Endocrinology Lutz, Natalie Linn Larson Barger, Katie Newbern, Dorothee Oatman, Oliver Wilson, Rochelle Shaibi, Gabriel Q Beauregard, Susan Velasquez, Amy Kapadia, Chirag R LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title | LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title_full | LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title_fullStr | LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title_full_unstemmed | LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title_short | LBODP082 Thresholds For Normal In Low Dose Cortrosyn Stimulation Depends On Assay Type |
title_sort | lbodp082 thresholds for normal in low dose cortrosyn stimulation depends on assay type |
topic | Pediatric Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625680/ http://dx.doi.org/10.1210/jendso/bvac150.1230 |
work_keys_str_mv | AT lutznatalielinnlarson lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT bargerkatie lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT newberndorothee lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT oatmanoliver lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT wilsonrochelle lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT shaibigabrielq lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT beauregardsusan lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT velasquezamy lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype AT kapadiachiragr lbodp082thresholdsfornormalinlowdosecortrosynstimulationdependsonassaytype |